Family history of Alzheimer’s disease limits improvement in cognitive function after bariatric surgery

SAGE Open Medicine

Volumn 2, Issue , 2014, Pages

  Alosco, Michael L ^a   Spitznagel, Mary Beth ^a   Strain, Gladys ^b   Devlin, Michael ^c   Crosby, Ross D ^d   Mitchell, James E ^d   Gunstad, John ^a  

^a KENT STATE UNIVERSITY   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c NewYork Presbyterian Hospital   (United States)

^d UND School of Medicine & Health Sciences Southeast Campus   (United States)

Author keywords

Alzheimer s disease; Bariatric surgery; Cognitive function; Obesity

Indexed keywords

EID: 85015528544     PISSN: None     EISSN: 20503121     Source Type: Journal    
DOI: 10.1177/2050312114539477     Document Type: Article

References (42)

1. Xu WL, Atti AR, Gatz M, et al. Midlife overweight and obesity increase late-life dementia risk: a population-based twin study. Neurology 2011; 76: 1568–1574.
2. Stanek KM, Strain G, Devlin M, et al. Body mass index and neurocognitive functioning across the adult lifespan. Neuropsychology 2013; 27: 141–151.
3. Yoon DH, Choi SH, Yu JH, et al. The relationship between visceral adiposity and cognitive performance in older adults. Age Ageing 2012; 41: 456–461.
4. Gunstad J, Strain G, Devlin MJ, et al. Improved memory function 12 weeks after bariatric surgery. Surg Obes Relat Dis 2011; 7: 465–472.
5. Miller LA, Crosby RD, Galioto R, et al. Bariatric surgery patients exhibit improved memory function 12 months post-operatively. Obes Surg 2013; 23: 1527–1535.
6. Alosco ML, Galioto R, Spitznagel MB, et al. Cognitive function after bariatric surgery: evidence for improvement 3 years after surgery. Am J Surgery, 2014; 207: 870-876.
7. Fratiglioni L, Ahlbom A, Viitanen M, et al. Risk factors for late-onset Alzheimer’s disease: a population-based, case-control study. Ann Neurol 1993; 33: 258–266.
8. Hayden KM, Zandi PP, West NA, et al. Effects of family history and APOE e4 status on cognitive decline in the absence of AD: the Cache County Study. Arch Neurol 2009; 66: 1378–1383.
9. Donix M, Burggren AC, Suthana NA, et al. Family history of Alzheimer’s disease and hippocampal structure in healthy people. Am J Psychiatry 2010; 167: 1399–1406.
10. Debette S, Wolf PA, Beiser A, et al. Association of parental dementia with cognitive and brain MRI measures in middle-aged adults. Neurology 2009; 73: 2071–2078.
11. Mosconi L, Rinne JO, Tsui WH, et al. Increased fibrillar amyloid-β burden in normal individuals with a family history of late-onset Alzheimer’s. Proc Natl Acad Sci U S A 2010; 107: 5949–5954.
12. Okonkwo OC, Xu G, Dowling NM, et al. Family history of Alzheimer disease predicts hippocampal atrophy in healthy middle-aged adults. Neurology 2012; 78: 1769–1776.
13. Belle SH, Berk PD, Courcoulas AP, et al. Safety and efficacy of bariatric surgery: Longitudinal Assessment of Bariatric Surgery. Surg Obes Relat Dis 2007; 3: 116–126.
14. Li G, Aryan M, Silverman JM, et al. The validity of the family history method for identifying Alzheimer’s disease. Arch Neurol 1997; 54: 634–640.
15. Donix M, Small GW and Bookheimer SY. Family history and APOE-4 genetic risk in Alzheimer’s disease. Neuropsychol Rev 2012; 22: 298–309.
16. Johnson SC, Schmitz TW, Trivedi MA, et al. The influence of Alzheimer disease family history and apolipoprotein E e4 on mesial temporal lobe activation. Neurobiol Dis 2006; 26: 6069–6076.
17. Honea RA, Swerdlow RH, Vidoni ED, et al. Progressive regional atrophy in normal adults with a maternal history of Alzheimer disease. Neurology 2011; 76: 822–829.
18. Paul RH, Lawrence J, Williams LM, et al. Preliminary validity of “integneuro”: a new computerized battery of neurocognitive tests. Int J Neurosci 2005; 115(11): 1549–1567.
19. Williams LM, Simms E, Clark CR, et al. The test-retest reliability of a standardized neurocognitive and neurophysiological test battery: “neuromarker.” Int J Neurosci 2005; 115: 1605–1630.
20. Reitan R. Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills 1958; 8: 271–276.
21. Walsh K. Understanding brain damage – a primer of neuropsychological evaluation. Melbourne, VIC, Australia: Churchill Livingstone, 1985.
22. Tabert MH, Manly JJ, Liu X, et al. Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment. Arch Gen Psychiatry 2006; 63: 916–924.
23. Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999; 56: 303–308.
24. Sarwer DB, Wadden T, Moore RH, et al. Preoperative eating behavior, postoperative dietary adherence, and weight loss after gastric bypass surgery. Surg Obes Relat Dis 2008; 4: 640–646.
25. Alosco ML, Cohen R, Spitznagel MB, et al. Older age does not limit post-bariatric surgery cognitive benefits: a preliminary investigation. Surg Obes Relat Dis, in press.
26. Kurz MW, Larsen JP, Kvaloy JT, et al. Associations between family history of Parkinson’s disease and dementia and risk of dementia in Parkinson’s disease: a community-based, longitudinal study. Mov Disord 2006; 21: 2170–2174.
27. Meyer JS, Rauch GM, Rauch RA, et al. Cardiovascular and other risk factors for Alzheimer’s disease and vascular dementia. Ann N Y Acad Sci 2000; 903: 411–423.
28. Johnson SC, Christian BT, Okonkwo OC, et al. Amyloid burden and neural function in people at risk for Alzheimer’s disease. Neurobiol Aging 2014; 35: 576–584.
29. Honea RA, Swerdlow RH, Vidoni ED, et al. Reduced gray matter volume in normal adults with a maternal family history of Alzheimer disease. Neurology 2010; 74: 113–120.
30. Bendlin BB, Ries ML, Canu E, et al. White matter is altered with parental family history of Alzheimer’s disease. Alzheimers Dement 2010; 6: 394–403.
31. Bangen KJ, Beiser A, Delano-Wood L, et al. APOE genotype modifies the relationship between midlife vascular risk factors and later cognitive decline. J Stroke Cerebrovasc Dis 2013; 22: 1361–1369.
32. Milone M, Di Minno MN, Leongito M, et al. Bariatric surgery and diabetes remission: sleeve gastrectomy or mini-gastric bypass? World J Gastroenterol 2013; 19: 6590–6597.
33. Terra X, Auguet T, Guiu-Jurado E, et al. Long-term changes in leptin, chemerin, and Ghrelin levels following different bariatric surgery procedures: Roux-en-Y Gastric bypass and sleeve gastrectomy. Obes Surg 2013; 23: 1790–1798.
34. Dimitriadis E, Daskalakis M, Kampa M, et al. Alterations in gut hormones after laparoscopic sleeve gastrectomy: a prospective clinical and laboratory investigational study. Ann Surg 2013; 257: 647–654.
35. Ghanim H, Monte SV, Sia CL, et al. Reduction in inflammation and the expression of amyloid precursor protein and other proteins related to Alzheimer’s disease following gastric bypass surgery. J Clin Endocrinol Metab 2012; 97: E1197– E1201.
36. Dos Santos VV, Rodrigues AL, De Lima TC, et al. Ghrelin as a neuroprotective and palliative agent in Alzheimer’s and Parkinson’s disease. Curr Pharm Des 2013; 19: 6773– 6790.
37. Zeki AL, Hazzouri A, Haan MN, et al. Central obesity, leptin and cognitive decline: the Sacramento Area Latino Study on Aging. Dement Geriatr Cogn Disord 2012; 33(6): 400–409.
38. Trollor JN, Smith E, Agars E, et al. The association between systemic inflammation and cognitive performance in the elderly: the Sydney Memory and Ageing Study. Age 2012; 34: 1295–1308.
39. Gunstad J, Lhotsky A, Wendell CR, et al. Longitudinal examination of obesity and cognitive function: results from the Baltimore longitudinal study of aging. Neuroepidemiology 2010; 34: 222–229.
40. Mrak RE. Alzheimer-type neuropathological changes in morbidly obese elderly individuals. Clin Neuropathol 2009; 28: 40–45.
41. Sager MA, Hermann B and La Rue A. Middle-aged children of persons with Alzheimer’s disease: APOE genotypes and cognitive function in the Wisconsin Registry for Alzheimer’s Prevention. J Geriatr Psychiatry Neurol 2005; 8: 245–249.
42. Falleti MG, Maruff P, Collie A, et al. Practice effects associated with the repeated assessment of cognitive function using the CogState battery at 10-minute, one week and one month test-retest intervals. J Clin Exp Neuropsychol 2006; 28: 1095– 1112.